Physician profile
Albert C Denault
NPI 1689656019
$11,657.43
in general payments reported to CMS, 2019-2025
36 companies · $772 in 2025
The $772 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,479 · 2020: $690 · 2021: $1,931 · 2022: $2,665 · 2023: $1,638 · 2024: $1,482 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,891.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,207.90 | 2019-2022 | |
| Sanara Medtech INC. | $1,448.82 | 2021-2023 | Celleraterx |
| Smith+Nephew, INC. | $1,111.80 | 2019-2025 | Renasys Touch, Stravix, Pico |
| Organogenesis INC. | $962.34 | 2019-2025 | Puraply, Apligraf, Nushield |
| Linvatec Corporation | $804.81 | 2019-2025 | Quantum, Biobrace 23mm, Colink Plating System |
| Next Science LLC | $520.20 | 2022-2024 | Blastx, Xperience, Surgx |
| Nevro Corp. | $472.85 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $350.17 | 2019-2021 | |
| Convatec INC. | $318.83 | 2023-2024 | |
| Wright Medical Technology, INC. | $263.60 | 2019-2020 | |
| Kerecis Limited | $224.03 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $217.84 | 2021-2024 | Nuzyra |
| Abbott Laboratories | $176.38 | 2024 | Proclaim |
| Biocomposites INC | $156.51 | 2019-2021 | |
| Forma Medical | $146.66 | 2025 | Optimalmtp |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $143.88 | 2020-2022 | |
| Integra Lifesciences Corporation | $131.05 | 2019-2020 | |
| Solventum Corporation | $124.14 | 2025 | Activ.A.C., Promogran Prisma |
| Aroa Biosurgery Incorporated | $122.16 | 2025 | |
| Nalu Medical, INC. | $110.66 | 2021 | |
| Cardiovascular Systems INC. | $86.85 | 2020 | |
| Coastal Medical Technologies LLC | $81.20 | 2023-2025 | |
| Polynovo North America LLC | $76.02 | 2024 | Novosorb Btm |
| Mimedx Group, INC. | $57.45 | 2024 | |
| Electronic Waveform Lab, INC. | $56.82 | 2020 | |
| Extremity Medical | $52.31 | 2024 | |
| Depuy Synthes Sales INC. | $49.68 | 2019-2025 | Motoband |
| Grt US Holding, INC. | $28.85 | 2021 | |
| Merck Sharp & Dohme LLC | $28.65 | 2019 | |
| Kci USA, INC. | $26.59 | 2020-2023 | 3m Coban, V.A.C. Dermatac |
| Axogen | $24.08 | 2021 | |
| Djo, LLC | $16.22 | 2025 | Cmf |
| Bsn Medical INC | $15.85 | 2025 | |
| Cashflow Solutions, LLC | $14.76 | 2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Bioventus LLC | $14.65 | 2021 | |
| Mvp Orthopedics INC | $12.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Denault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.